This press release is issued pursuant to Multilateral Instrument 62-104 – Take-Over Bids and Issuer Bids and National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in respect of Field Trip Health & Wellness Ltd. (the “Company“).
GEORGE TOWN, Cayman Islands, Aug. 11, 2022 /CNW/ – On August 11, 2022, Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd.) (“Reunion“) and the Company completed Reunion’s previously announced corporate restructuring transactions as contemplated under the Amended and Restated Arrangement Agreement dated May 18, 2022, which included, among other things, (i) each shareholder of Reunion receiving approximately 0.85983356 of a common share in the capital of the Company (“Share“) for each common share held by such shareholder in the capital of Reunion, (ii) Reunion transferring to the Issuer…
